EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cuproptosis: emerging biomarkers and potential therapeutics in cancers

Min Wang, Lianwen Zheng, Shuai Ma, Ruixin Lin, Jiahui Li, Shuli Yang

Frontiers in Oncology · 07.11.2023 · 13

DOI: 10.3389/fonc.2023.1288504 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 07.11.2023. Verfasst von Min Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The Second Hospital of Jilin University, Changchun, China. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The sustenance of human life activities depends on copper, which also serves as a crucial factor for vital enzymes. Under typical circumstances, active homeostatic mechanisms keep the intracellular copper ion concentration low. Excess copper ions cause excessive cellular respiration, which causes cytotoxicity and cell death as levels steadily rise above a threshold. It is a novel cell death that depends on mitochondrial respiration, copper ions, and regulation. Cuproptosis is now understood to play a role in several pathogenic processes, including inflammation, oxidative stress, and apoptosis. Copper death is a type of regulatory cell death(RCD).Numerous diseases are correlated with the development of copper homeostasis imbalances. One of the most popular areas of study in the field of cancer is cuproptosis. It has been discovered that cancer angiogenesis, proliferation, growth, and metastasis are all correlated with accumulation of copper ions. Copper ion concentrations can serve as a crucial marker for cancer development. In order to serve as a reference for clinical research on the product, diagnosis, and treatment of cancer, this paper covers the function of copper ion homeostasis imbalance in malignant cancers and related molecular pathways.

Schlagwörter

Stichwörter der Autor:innen

cancercell deathcoppercuproptosisimmunotherapymetabolismmolecular targeted therapy

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, The Second Hospital of Jilin University, Changchun, China.
  • Department of Hepato-Biliary-Pancreatic Surgery, The Second Hospital of Jilin University, Changchun, China.

Zitieren

APA

Wang, M., Zheng, L., Ma, S., Lin, R., Li, J., & Yang, S. (2023). Cuproptosis: emerging biomarkers and potential therapeutics in cancers. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1288504

Vancouver

Wang M, Zheng L, Ma S, Lin R, Li J, Yang S. Cuproptosis: emerging biomarkers and potential therapeutics in cancers. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1288504

BibTeX
@article{Wang2023,
  author = {Wang, Min and Zheng, Lianwen and Ma, Shuai and Lin, Ruixin and Li, Jiahui and Yang, Shuli},
  title = {Cuproptosis: emerging biomarkers and potential therapeutics in cancers},
  journal = {Frontiers in Oncology},
  year = {2023},
  volume = {13},
  doi = {10.3389/fonc.2023.1288504}
}
Kostenlos starten →